WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for ASND

Based on 12 analysts offering 12 month price targets for Ascendis Pharma A.
Min Forecast
$117.00-3.03%
Avg Forecast
$151.67+25.7%
Max Forecast
$174.00+44.21%

Should I buy or sell ASND stock?

Based on 12 analysts offering ratings for Ascendis Pharma A.
Strong Buy
Strong Buy
6 analysts 50%
Buy
5 analysts 41.67%
Hold
1 analysts 8.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ASND stock forecasts and price targets.

ASND stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 11%
11
Strong BuyMaintains$148.00+22.66%2022-11-15
SVB Leerink
Bottom 3%
3
BuyMaintains$148.00+22.66%2022-11-14
Wedbush
Bottom 26%
26
BuyMaintains$164.00+35.92%2022-11-14
Wells Fargo
Top 4%
97
Strong BuyMaintains$169.00+40.06%2022-11-07
Credit Suisse
Bottom 2%
2
BuyMaintains$130.00+7.74%2022-11-03
Citigroup
Top 22%
79
Strong BuyMaintains$163.00+35.09%2022-11-03Find out why
Goldman Sachs
Bottom 12%
12
Strong BuyInitiates Coverage On$174.00+44.21%2022-10-20
Berenberg
Top 36%
65
Strong BuyAssumes$166.00+37.58%2022-08-30
Oppenheimer
Bottom 5%
5
BuyMaintains$144.00+19.34%2022-08-11
Anonymous
Morgan Stanley
Strong BuyMaintains$197.00+63.27%2022-03-15

1 of 2

Forecast return on equity

Is ASND forecast to generate an efficient return?
Company
-45.09%
Industry
15.35%
Market
62.84%
ASND's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ASND forecast to generate an efficient return on assets?
Company
-15.99%
Industry
13.55%
ASND is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ASND earnings per share forecast

What is ASND's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$8.77
Avg 2 year Forecast
-$9.59
Avg 3 year Forecast
-$7.37

ASND revenue forecast

What is ASND's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$39.0M+17.62%
Avg 2 year Forecast
$127.3M+283.81%
Avg 3 year Forecast
$351.3M+959.04%
ASND's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ASND revenue growth forecast

How is ASND forecast to perform vs Biotechnology companies and vs the US market?
Company
115.21%
Industry
24.83%
Market
6.69%
ASND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ASND vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ASND$120.66$151.67+25.70%Strong Buy
KRTX$200.79$270.50+34.72%Strong Buy
HALO$56.38$58.60+3.94%Strong Buy
LEGN$53.96$64.50+19.53%Strong Buy
IONS$38.03$48.50+27.53%Buy

Ascendis Pharma A Stock Forecast FAQ

Is Ascendis Pharma A Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: ASND) stock is to Strong Buy ASND stock.

Out of 12 analysts, 6 (50%) are recommending ASND as a Strong Buy, 5 (41.67%) are recommending ASND as a Buy, 1 (8.33%) are recommending ASND as a Hold, 0 (0%) are recommending ASND as a Sell, and 0 (0%) are recommending ASND as a Strong Sell.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

What is ASND's earnings growth forecast for 2022-2024?

(NASDAQ: ASND) Ascendis Pharma A's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Ascendis Pharma A's earnings in 2022 is -$472,386,274.On average, 8 Wall Street analysts forecast ASND's earnings for 2022 to be -$500,128,895, with the lowest ASND earnings forecast at -$536,626,328, and the highest ASND earnings forecast at -$465,912,551. On average, 8 Wall Street analysts forecast ASND's earnings for 2023 to be -$546,891,232, with the lowest ASND earnings forecast at -$647,829,446, and the highest ASND earnings forecast at -$378,090,601.

In 2024, ASND is forecast to generate -$420,290,759 in earnings, with the lowest earnings forecast at -$544,610,142 and the highest earnings forecast at -$212,141,333.

What is ASND's revenue growth forecast for 2022-2024?

(NASDAQ: ASND) Ascendis Pharma A's forecast annual revenue growth rate of 115.21% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Ascendis Pharma A's revenue in 2022 is $32,524,509.On average, 5 Wall Street analysts forecast ASND's revenue for 2022 to be $2,225,316,959, with the lowest ASND revenue forecast at $1,910,412,540, and the highest ASND revenue forecast at $2,390,581,901. On average, 5 Wall Street analysts forecast ASND's revenue for 2023 to be $7,261,278,469, with the lowest ASND revenue forecast at $3,596,137,754, and the highest ASND revenue forecast at $10,134,881,093.

In 2024, ASND is forecast to generate $20,035,665,365 in revenue, with the lowest revenue forecast at $8,817,551,849 and the highest revenue forecast at $31,601,074,774.

What is ASND's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: ASND) forecast ROA is -15.99%, which is lower than the forecast US Biotechnology industry average of 13.55%.

What is ASND's Price Target?

According to 12 Wall Street analysts that have issued a 1 year ASND price target, the average ASND price target is $151.67, with the highest ASND stock price forecast at $174.00 and the lowest ASND stock price forecast at $117.00.

On average, Wall Street analysts predict that Ascendis Pharma A's share price could reach $151.67 by Nov 15, 2023. The average Ascendis Pharma A stock price prediction forecasts a potential upside of 25.7% from the current ASND share price of $120.66.

What is ASND's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ASND) Ascendis Pharma A's current Earnings Per Share (EPS) is -$8.40. On average, analysts forecast that ASND's EPS will be -$8.77 for 2022, with the lowest EPS forecast at -$9.41, and the highest EPS forecast at -$8.17. On average, analysts forecast that ASND's EPS will be -$9.59 for 2023, with the lowest EPS forecast at -$11.36, and the highest EPS forecast at -$6.63. In 2024, ASND's EPS is forecast to hit -$7.37 (min: -$9.55, max: -$3.72).

What is ASND's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: ASND) forecast ROE is -45.09%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.